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ABSTRACT 
Minimal research has been conducted to understand the relationship between psychosocial 
factors, fatigue, and quality of life among adolescents living with HIV. We studied 134 South 
African adolescents receiving an antiretroviral therapy (ART) at community clinics to 
examine the relationship between fatigue, sleep disturbance, depression, anxiety, pain and 
quality of life. Participants reported low levels of fatigue, insomnia, distress and pain and 
non-problematic levels of quality of life (QOL). In the regression model, the linear 
combination of these variables explained 49% of the variance in quality of life. Insomnia, 
anxiety, and depression significantly predicted quality of life but fatigue and pain did not. 
Future research may address the relationship between self-reported adherence and QOL, 
possibly by examining the role of viral load (VL) as a mediating variable. Further research 
may also focus on non-adherent adolescents to understand the ways in which fatigue and 
other factors such as school functioning and social interaction influence QOL.  
Key words: Quality of life, adolescents, fatigue, antiretroviral therapy 
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HIV prevalence among South Africans remains unacceptably high, with an estimated 
12.7% of the general population and 5.6% of 15 to 24-year olds living with the virus. In 
2012, 24% and 6% of new HIV infections in South Africa were among young women and 
men between the ages of 15 to 24, respectively [1]. The prevalence estimate for this age 
group was 7.1% (6.2%-8.1%) with females 8 times more likely than males to be infected. It is 
therefore apparent that girls are demographic group that is vulnerable to HIV. Behavioural 
factors that make adolescents susceptible to HIV infection include age-disparate sex, multiple 
partnerships, sex work and sexually exploited adolescent girls, transactional sex, early sexual 
debut, gaps in knowledge, and limited understanding of risk. Biological factors include the 
biological susceptibility of women, especially adolescent girls such as the HIV-susceptibility 
of the immature cervix, high HIV viral load (VL) among male partners, low prevalence of 
male circumcision, and harmful practices such as using substances to dry the vagina. 
Structural factors include gender inequality, unequal power dynamics, low secondary school 
attendance, barriers to accessing sexual and reproductive health services, orphanhood, child 
sexual abuse, and gender-based violence. 
With the availability of ART, HIV has become a chronic rather than a life-threatening 
condition. South Africa has the largest number of persons enrolled in its ART programme in 
the world [2]. It is estimated that approximately 7.03 million South Africans were living with 
HIV in 2016.  
There are several reasons that it is necessary to document and understand QOL among 
South African adolescents living with HIV. Firstly, with the advent of antiretroviral therapy, 
the longevity of persons living with HIV has increased to the extent that they may live well 
into their seventies and eighties. Evidence exists that starting ART immediately following 
diagnosis with HIV results in greater improvements in QOL compared to deferring treatment 
[3]. It has also been shown that improvement in QOL is associated with starting second line 
  Predictors of quality of life  
4 
 
ART, presumably following poor adherence to first line ART and consequent health 
deterioration [4]. To this extent, QOL is a necessary and important aspect of health to 
consider. Secondly, a substantial proportion of the South African adolescent population is 
currently living with HIV, indicating that QOL is a salient phenomenon for several thousand 
individuals. Indeed, it is estimated that in sub-Saharan Africa there are over 1.7 million 
adolescents living with HIV [5]. Thirdly, developmental differences mean that findings from 
the adult literature may not simply be applied to adolescents as their QOL experiences are 
unique and idiosyncratic. Fourthly, there is a need to understand the factors that contribute to 
QOL so that knowledge can be generated about where best to target interventions to ensure 
adolescents with HIV have optimal QOL given their life circumstances. To this extent, 
findings from this research may assist in identifying potential treatment targets for improving 
QOL and decreasing disease burden. 
QOL among adolescents living with HIV 
Previous psychosocial research on adolescents living with HIV has focused on mental 
health concerns, sexual risk behaviour, and the effect of educational programmes to reduce 
HIV incidence [6]. There appears to be minimal research on QOL among adolescents living 
with HIV.  Using the search terms “adolescents”, “quality of life”, “HIV” and “Africa” we 
were able to find only two articles published in the last five years. Among Ugandan 
adolescents, receiving ART was associated with improved physical and mental health but 
poor communication with caregivers regarding sexuality or dissatisfaction with sexual and 
reproductive health services was associated with poor mental health [7]. Among Ghanaian 
adolescents who acquired HIV peri-natally more than two thirds were not virally suppressed 
and many reported barriers to treatment adherence, limited social support, concerns about 
disclosure and HIV-related stigma, limited resources, and low quality of life (QOL) [8]. One 
study among adolescents with HIV in the south-eastern United States found that health-
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related QOL was correlated with life satisfaction and social-emotional strength and 
negatively correlated with negative affect and psychopathology symptoms [9].  
QOL and Fatigue 
Fatigue is a reduction in capacity for physical engagement in activities. The term 
“chronic fatigue” has come to refer to fatigue that is disproportionate to the nature of the task 
that is undertaken, persists for at least 1 month, and has no discernible cause [10]. 
Precipitating factors for chronic fatigue include psychological stress, dysfunction of the 
hypothalamus, pituitary, and adrenal glands, hormonal imbalance, infection, and suppression 
of the immune system [11]. Chronic fatigue has been observed in a range of illness conditions 
in adolescents such as rheumatoid arthritis[12], chronic pain[13], neurological conditions 
[14], multiple sclerosis [15], as well as in HIV in adults [16] and has been associated with 
low QOL (e.g. [17, 18]). 
Persons living with HIV (PLWH) commonly experience elevated fatigue, which has 
been shown to be associated with poor engagement with treatment [19] thus yielding poor 
QOL. Low rates of ART adherence is a strong predictor of HIV-related infections and 
mortality. Fatigue may affect ART adherence, for example, due to oversleeping, impaired 
concentration, and a lack of physical energy to attend clinic appointments. For example, in a 
three-year longitudinal study of 128 PLWH, it was found that HIV-related fatigue was 
chronic and persistent in that spontaneous remission did not occur [20]. In addition, fatigue 
impeded work, family, and social life activities and was exacerbated by stress and depression. 
To our knowledge, no studies have shown a relationship between fatigue and QOL among 
adolescents living with HIV. In terms of the biopsychosocial model, it is likely and plausible 
that fatigue, as well as other related symptomatology such as sleep disturbance, pain, 
depression and anxiety are associated with QOL among PLWH. 
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QOL and insomnia: Insomnia has been shown to be associated with QOL in various 
populations such as cancer patients [21], patients with Type II diabetes [22]; and epilepsy 
[23]. 
One study of 206 patients admitted to a sleep disorder centre found that elevated levels of 
fatigue was associated with psychophysiological insomnia [24]. Yet, in this study daytime 
sleepiness was not predictive of fatigue and the two phenomena were therefore considered to 
be independent of each other. We found no studies on fatigue and insomnia among 
adolescents living with HIV, and to this extent the present investigation is the first of its kind. 
QOL and distress: An intervention study to ameliorate symptoms of depression among 
PLWH showed that improvement in depression scores was associated with better physical 
and mental QOL, reduced fatigue intensity, as well as improvements in HIV symptoms [25]. 
Indeed, the symptom picture for major depression includes insomnia or hypersomnia nearly 
every day and fatigue or loss of energy nearly every day. Thus, in all likelihood, both 
insomnia and fatigue are likely to be common among depressed individuals.  
Pain, an important dimension of QOL, is commonly reported among PLWH [26] and 
the virus may directly affect the musculoskeletal system [27]. Among 261 patients living with 
HIV in Brazil, more than half the sample reported moderate pain or severe pain, which was 
negatively associated with QOL[28]. Common pain diagnoses include multiple syndromes, 
degenerative disc disease or spinal stenosis, and neuropathy [29]. We were unable to find any 
studies on pain and QOL among adolescents living with HIV.  
While the relationship between QOL, fatigue and psychological distress among 
adolescents living with HIV is largely unexplored, they have been shown to be highly 
correlated in other populations such as adults living with HIV [30, 31]; cardiac patients [32]; 
oncology patients [33]; and patients receiving treatment for multiple sclerosis [34]. A recent 
review found that employment, immunological status, presence of symptoms, depression, 
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social support and adherence to antiretroviral therapy were associated with health-related 
quality of life among individuals living with HIV [35]. Yet, as has been shown by a 
systematic review of reviews of QOL measurement instruments, concerns about valid 
measures of QOL abound [36]. In this study, we examined the relationship between fatigue, 
sleep disturbance, depression, anxiety, pain and QOL among adolescents receiving ART.  
Methods 
Participants 
We recruited male and female adolescents, ages 11 to 18 years, enrolled in an ART 
programme at a community clinic and a district hospital in the Western Cape Province of 
South Africa. Inclusion criteria were competence in English or Afrikaans, the two most 
commonly-spoken languages in the province. Exclusion criteria were evidence of 
developmental delay, specifically difficulties with communication, or a diagnosis with a 
severe mental condition. 
Procedure 
Clinic staff informed eligible adolescent patients about the study during routine clinic 
visits. Those adolescents who indicated an interest in learning more about the study were 
referred to a research assistant in a private room at the clinic, where the study was explained 
in greater detail and the patient was invited to participate. The research assistant followed the 
established procedures for gaining informed consent. We received ethics clearance for a 
parental waiver of consent, given that most of our participants attended their consultations 
alone. All participants were clinician referred.   
The questionnaire battery was presented to participants in English or Afrikaans, 
depending on participant preference. The battery was self-administered by participants. If 
they indicated difficulty in understanding specific questions, they were helped by the research 
assistant. The translation of the Chalder Fatigue Questionnaire (CFQ) and the Revised Child 
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Anxiety and Depression Scale (RCADS) was conducted by a bilingual post-graduate 
psychology student and the Afrikaans version was then checked by one of the authors (BC). 
However, we did not conduct a back-translation of these measures.   
Measures 
QOL: Pediatric QOL Inventory (PedsQLTM4.0 short form SF15) [37] was used to 
measure QOL among the sample. The PedsQL is a 23-item questionnaire that is appropriate 
for use among individuals up to the age of 18. The instrument has four subscales, namely, 
physical functioning, emotional functioning, social functioning, and school functioning. It 
yields a physical health (8 items), psychosocial health (15 items), and total QOL summary 
score (23 items). The PedsQL has good psychometric properties including alpha reliability of 
0.90 for the children’s version. It has been shown to validly distinguish between healthy 
children and those with a health condition, as well as disease severity within a chronic health 
condition.  
Fatigue: We used the CFQ [38] to assess fatigue. The CFQ is a four-point Likert-type scale 
with 11 items that assesses the severity of both mental and physical fatigue within the past 
month. The CFQ has been used among populations with a range of health conditions [39], 
including adolescents with fatigue [40, 41]. We used the Likert method of scoring the scale, 
i.e. we calculated the total score out of a possible 33, with a score of > 18 indicating elevated 
fatigue [42].  
Insomnia: We used the 8 item Athens Insomnia Scale (AIS) to assess insomnia. The AIS is a 
four-item Likert-type scale that enquires about sleep problems that occur for the respondent 
three times per week during the previous month. The items assess sleep induction, 
awakenings during the night, final awakening, sleep duration, sleep quality, well-being, 
functioning capacity, and daytime sleepiness. The AIS has been shown to have high internal 
consistency, with an alpha coefficient of 0.90 [43]. 
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Depression: The RCADS contains a 10-item depression subscale, designed to assess mood in 
children ages 7-18[44]. Items pertain to feeling sad or empty, anhedonia, sleep and appetite 
disturbance, having no energy and feeling tired, feelings of worthlessness, and feeling 
restless.  
Anxiety: The RCADS also contains 6 items that pertain to symptoms of anxiety, i.e. worrying 
about things, worrying about bad things happening, and thinking about death. Both the 
depression and anxiety subscales of the RCADS have been shown to have high validity and 
reliability in both clinical and nonclinical populations [44–47]. For the statistical analysis, we 
converted the raw scores on the RCADS into a T-score with a mean of 50 and standard 
deviation of 10 [48]. On both the depression and anxiety subscales of the RCADS, a 
converted score of 65 indicates possible clinical significance and a converted score of 70 
indicates probable clinical significance [49]. 
Pain: To assess pain, we used a Visual Analogue Pain Scale (VAPS). Participants were asked 
to mark on a line the severity of their pain from no pain at all to pain as bad as possible.  
A VAPS has often been used to measure the intensity or frequency of pain. It is assumed that 
the intensity of pain felt by a participant ranges from none to an extreme amount on a 
continuous spectrum rather than taking discrete jumps as would be indicated on a Likert-type 
scale [50]. A cut-point of 4 was used to distinguish between clinically significant and non-
significant pain. 
Cronbach’s alpha of all the assessment instruments exceeded 0.80, indicating very 
high internal consistency of the scales. Means, standard deviations and minimum and 
maximum scores of the sample on the various measures are presented in Table 2. 
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Ethical considerations 
We obtained ethics approval for this study from the Stellenbosch University Research 
Ethics Committee and the Western Cape Department of Health. Participants were asked to 
complete an informed consent form and were assured of confidentiality of their data. 
Data analysis 
We used SPSS v24 to analyse the data. The analysis included calculating Cronbach’s 
alpha to determine the internal consistency of the scales used and descriptive statistics to 
describe the demographic variables. We used Pearson’s r to calculate bivariate correlations 
among the variables and linear regression analysis to determine the linear contribution of the 
predictor variables, i.e. fatigue, insomnia, anxiety, depression and pain, on the criterion 
variable, i.e. QOL. To determine gender differences among the variables, we conducted t-
tests with a Bonferroni correction. The sample size was adequate using a rule of thumb of 15 
participants per predictor variable.  
Results 
Description of the sample 
As shown in Table 1, we recruited 134 adolescents (78 female and 56 male) whose 
mean age was 14.33 years. Twenty-four (17.9%) of the participants endorsed the “coloured” 
racial group and 110 (82.1%) identified as Black. All participants except one were in high 
school and one was employed part-time. More than half the sample identified as Christians. 
QOL: As can be seen in Table 2, the sample reported on average high QOL on the physical, 
emotional, social and school QOL domains, as well as the total score for the measure. The 
total mean score on the PedsQL was 24.56 (SD=13.71), which was significantly lower than 
the cut-point of 70 indicating problematic levels of QOL [51]. Females reported significantly 
lower QOL than males. 
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Fatigue: The mean score on the CFQ was 14.89 (SD=3.82) out of a possible total score of 33. 
The mean score was significantly lower (t=−9.42; df=133; p<0.00) than the commonly used 
cut-point of 18 [52], which indicates that the average fatigue level of the sample was within 
the normal range. Clinically significant fatigue on the CFQ is considered to be 19 and above 
[52]. There were no significant differences between males and females on the CFQ.  
Insomnia: The mean score on the AIS was 3.92 (SD=3.38) out of a possible total score of 24. 
The mean score was significantly lower (t=−10.52; df=133; p=0.00) than the commonly used 
cut-point of 7 [53], which indicates sleep problems that occur out of the normal range. 
Clinically significant insomnia on the AIS is considered to be 7 and above. 
Depression: The mean converted T-score on the RCADS Depression subscale was 44.70 
(SD=12.33). The mean score was significantly lower (t=−19.05; df=133; p=0.00) than the 
threshold of 65, indicating the probability of clinically significant depression, and only 5.2% 
scored in the clinically significant range. On average our sample represented non-depressed 
adolescents. 
Anxiety: The mean converted T-score on the RCADS Anxiety subscale was 43.9 (SD=12.78). 
The mean score was significantly lower (t=−19.11; df=133; p=0.00) than the threshold of 65, 
indicating the probability of clinically significant anxiety, and only 9.0% of the sample 
scored in the clinically significant range. On average our sample represented non-anxious 
adolescents.  
Pain: The mean score on the VAPS was 0.82 (SD=1.82) out of a possible total score of 7. 
The mean score was significantly lower (t=−19.87; df=133; p=0.00) than the threshold of 4 
on the VAPS, indicating at least mild pain [54]. 
Bivariate correlations 
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Table 3 presents the correlation coefficients among the variables of interest. QOL 
highly and significantly correlated with insomnia, depression, anxiety, and fatigue but not 
pain.  
We found significant correlations between depression, insomnia and fatigue, and 
between anxiety and insomnia. Scores on the pain measure were not found to be associated 
with any of the variables included. 
Results of the regression analysis 
The various regression diagnostics, including the Cook's and Mahalanobis distances, 
and variance inflation factors were within the acceptable range for regression analysis. The 
data were normally distributed making it possible to conduct a regression analysis. Table 4 
presents the regression model summary with QOL as the criterion variable. The linear 
combination of the predictors, namely, insomnia, fatigue, anxiety and depression explained 
49% of the variance in QOL, a large effect size [55]. Table 5 shows that insomnia, anxiety 
and depression were unique significant predictors of QOL. Neither fatigue nor pain emerged 
as significant predictors of QOL. 
Discussion 
On average participants in this study reported levels of insomnia, fatigue, anxiety, 
depression and pain that fell in the normal ranges on the instruments that assessed these 
variables. This finding is positive in that it appears that many members of the sample 
experienced non-clinical levels of sleep disturbance, fatigue and psychosocial distress in 
comparison with the commonly used cut-points of the measures that assessed these 
constructs.  
In previous research, symptoms of depression and anxiety have been shown to be 
common among adolescents with HIV [56–58]. However, very few members of our sample 
scored in the elevated range on the depression and anxiety measures. Similarly, QOL was 
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within the normal range. These findings are surprising it would be assumed that adolescents 
living with HIV, especially those of poorer socio-economic backgrounds, would experience 
lower QOL than those from middle class backgrounds. That our data refute this assumption is 
certainly a novel finding and provides some evidence that living with HIV need not result in 
poor QOL or excessive fatigue, at least in a clinic-attending population.  
The linear combination of our predictor variables explained just under 50% of the 
variance in QOL, which is a large effect size. Insomnia, anxiety, and depression were 
significant predictors in the model. Even though scores on the instruments measuring these 
variables fell in the non-clinical range, they were still robustly predictive of poor QOL.  
However, we were surprised that neither fatigue nor pain emerged as significant 
predictors. Our data contradict that of previous research indicating that, at least for some, 
fatigue is predictive of QOL [59]. The level of pain reported among our sample was minimal, 
presumably accounting for the fact that it did not emerge as a significant factor in the model.    
By identifying which of several biopsychosocial factors investigated contribute most 
substantially to QOL in this population, our findings suggest what might be most important to 
address, both in terms of research and in clinical practice. Our findings are not entirely 
consistent with findings in the adult HIV literature, illustrating the importance of undertaking 
this research with the adolescent population. By virtue of their developmental stage and its 
associated factors, for example, being in school rather than economically active, and being 
dependent upon others rather than autonomous, QOL may be maximised by different 
processes. It was somewhat surprising but also reassuring to find non-problematic levels of 
QOL among our participants. This finding suggests that adolescents receiving ART may live 
satisfying lives and may not be unduly limited by physical or mental health complaints.   
The strengths of the study include the fact that this is among only a few studies to 
examine QOL among adolescents living with HIV in Africa and as far as we know the only 
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one in South Africa. Also, we recruited adolescents who were enrolled on a state-sponsored 
anti-retroviral therapy programme and were actively receiving HIV-related care.   
We have identified some limitations to the study. First, this was a cross-sectional 
study, which imposes limitations on any claims about causal relationships among the 
variables. Second, we did not report data on VL. VL is highly influenced by ART adherence 
levels [60] and predicts HIV-related symptoms [61] and thus health-related QOL. At the 
clinical sites where the study was conducted, the testing and capturing of VL was inconsistent 
and thus these data were not usable. It is possible that the sample consisted of highly adherent 
individuals, as they were recruited at the clinics where they were seeking treatment. This 
could explain why their QOL was within normal limits. Third, it is possible that acceptance 
of the HIV diagnosis may increase with time, resulting in the natural amelioration of 
symptoms of depression and anxiety. However, we did not collect data on time since 
diagnosis and therefore could not test this hypothesis.   
 Future research may address the relationship between medication adherence and 
QOL, possibly by examining the role of fatigue as a mediating variable. For example, 
oversleeping, impaired concentration, and a lack of physical energy to attend clinic 
appointments are expressions of fatigue which may affect ART adherence. Nonetheless, the 
study shows a robust relationship between sleep disturbance, psychosocial factors such as 
depression and anxiety and QOL among our sample. Further research may focus on non-
adherent adolescents to understand the ways in which fatigue and other factors such as school 
functioning and social interaction influence QOL. For example, Loades, Coetzee, Du Toit 
and Kagee (2018) found that South African adolescents enrolled on the national ART 
programme reported impaired social interaction, poor concentration and memory, and low 
levels of energy which influenced their ability to function at school[62].   
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The cognitive and behavioural responses to fatigue in this population have not been 
investigated, and therefore, further research is needed to explore these factors and the 
appropriateness of a cognitive behavioural model in conceptualising fatigue among 
adolescents with HIV. Given the criticisms of research into cognitive therapy to ameliorate 
symptoms of chronic fatigue, this line of investigation may be especially timely. Considering 
the overlap between mood disturbance and fatigue, and the fact that fatigue forms part of the 
symptom picture for major depressive disorder, research into specific interventions such as 
behavioural activation and exercise scheduling is also indicated.  
Conclusion 
In the context of public health systems in the global South that are increasingly 
resource-constrained, it is appropriate to consider task-shifting of clinical functions 
previously provided by highly trained psychologists and psychiatrists to lower level nurses, 
peer counsellors, and patient advocates. Evidence for the effectiveness of such interventions 
would be of considerable use to policy-makers concerned with the psychosocial well-being of 
adolescents living with HIV. 
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Table 1. Sample characteristics 
    Frequency  (%) M SD 
Age (in years)    14.33 1.99 
      
Gender Female 78 58.2   
 Male 56 41.8   
      
Ethnicity Coloured 24 17.9   
 Black 110 82.1   
      
Social Class Lower 94 70.1   
 Working 38 28.4   
 Middle 2 1.5   
      
Religion Christian 75 56.0   
 Protestant 1 0.7   
 Catholic 1 0.7   
 Pentacostal 1 0.7   
 Methodist 2 1.5   
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Table 2: Descriptive statistics 
 
 Min and max scores Mean SD 
PedsQL Physical 0-32 7.07 5.70 
PedsQL Emotional 0-20 6.97 4.07 
PedsQL Social 
0-20 3.34 4.41 
PedsQL School 
0-20 7.14 3.71 
PedsQL Total 0-92 24.56 13.71 
Chalder Fatigue Scale 0-33 14.89 3.82 
Athens Insomnia Scale 0-24 3.92 3.38 
RCADS-Depression 0-30   
RCADS-Anxiety 0-18   
Visual Analogue Pain Scale 1-7 0.86 1.82 
 
  
  Predictors of quality of life  
28 
 
 
Table 3: Bivariate correlation matrix of variables  
 (1) (2) (3) (4) (5) (6) 
       
(1) QOL 1      
(2) Insomnia 0.57* 1     
(3) Depression 0.60* 0.42* 1    
(4) Anxiety 0.43* 0.24* 0.54* 1   
(5) Fatigue 0.49* 0.56* 0.46* 0.16 1  
(6) Pain −0.02 0.2 −0.2 −0.06 0.13 1 
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Table 4: Model summary with QOL as the criterion variable 
Outcome  Model Predictors R R square Adj R 
square 
R square 
change 
F ratio F change 
         
Peds QOL 1 Constant, Insomnia (Athens) 0.57 0.32 0.31 0.32 62.01 0.00 
 2 Constant, Insomnia, Fatigue 0.60 0.37 0.36 0.05 37.58 0.00 
 3 Constant, Insomnia, Fatigue, Anxiety, 
Depression 
0.71 0.51 0.49 0.14 33.16 0.00 
 4 Constant, Insomnia, Fatigue, Anxiety, 
Depression, Pain 
0.71 0.51 0.49 0.00 26.43 0.605 
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Table 5: Predictors of quality of life 
Model Unstandardized Coefficients 
Standardized 
Coefficients  
 
 B Standard Error Beta t p 
Constant −11.23 4.52   0.01 
Insomnia 1.27 0.31 0.31 −2.49 0.00 
Fatigue 0.54 0.29 0.15 4.09 0.06 
Anxiety 0.16 0.08 0.15 1.87 0.04 
Depression 0.35 0.09 0.32 2.03 0.00 
Pain −0.25 0.47 −0.03 −0.52 0.61 
 
 
 
 
